News | May 12, 2024
Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.8.29 crores for the Financial Year ended March 31, 2024
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Investing in Malaysia's largest clinic operator to expand the healthcare business
Aptar Closures’ E-Disc Top securely protects against in-transit leakage while eliminating the need for liners and extra shipping preparation fees
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated
